A large-scale cohort study of SCLC revealed that the presence of genetic alterations in the PI3K/AKT/mTOR pathway are strongly associated with poor survival of patients with ED-SCLC [18]. This evidence concerns the gene PIK3CA and small cell lung carcinoma.